Major block deals dominated trading activity on Tuesday as PFL Employee Welfare Trust sold shares worth ₹222.96 crore in Poonawalla Fincorp, while Goldman Sachs acquired approximately ₹100 crore worth of shares in Sudeep Pharma through open market transactions.
According to exchange block deal data, PFL Employee Welfare Trust offloaded 47.08 lakh equity shares, representing 0.53% of Poonawalla Fincorp’s paid-up equity, in a transaction valued at ₹222.96 crore.
The identity of the buyers in the Poonawalla Fincorp block deal was not immediately disclosed.
Goldman Sachs Buys Sudeep Pharma Shares
In another notable transaction, Goldman Sachs purchased ₹100 crore worth of shares in Sudeep Pharma through the open market, highlighting continued institutional interest in select mid-cap healthcare stocks.
The deal comes amid sustained activity by domestic and global institutional investors in India’s equity markets.
Institutional Activity Remains Strong
Large block transactions often reflect portfolio rebalancing, strategic investments, or stake monetisation by institutional investors. Tuesday’s deals underline the continued participation of marquee global investors in Indian equities.
The transactions also come at a time when institutional activity has remained elevated across sectors including financial services and pharmaceuticals.
While PFL Employee Welfare Trust reduced its holding in Poonawalla Fincorp, Goldman Sachs’ investment in Sudeep Pharma signals confidence in opportunities within the pharmaceutical space.
Market participants will continue tracking future shareholding disclosures to identify the counterparties involved in the Poonawalla Fincorp transaction and assess any impact on investor sentiment.
